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Abstract: 
Surfactant protein C (SP-C) deficiency is found in samples from patients suffering idiopathic pulmonary 
fibrosis (IPF), especially in familial forms of this disease. We hypothesized that SP-C may contribute to 
fibrotic remodeling in aging mice and alveolar lipid homeostasis. For this purpose, we analyzed lung 
function, alveolar dynamics, lung structure, collagen content and expression of genes related to lipid and 
cholesterol metabolism of aging SP-C knock out mice. In addition, in vitro experiments with an alveolar 
macrophage cell line exposed to lipid vesicles with/without cholesterol and/or SP-C were performed. 
Alveolar dynamics showed progressive alveolar de-recruitment with age and impaired oxygen saturation. 
Lung structure revealed that decreasing volume density of alveolar spaces was accompanied by increasing 
of the ductal counterparts. Simultaneously, septal wall thickness steadily increased, and fibrotic wounds 
appeared in lungs from the age of 50 weeks. This remarkable phenotype is unique to the 129Sv strain, 
which has an increased absorption of cholesterol, linking the accumulation of cholesterol and the absence 
of SP-C to a fibrotic remodeling process. The findings of this study suggest that overall loss of SP-C results 
in an age-dependent complex, heterogeneous phenotype characterized by a combination of over distended 
air spaces and fibrotic wounds that resembles CEPF (Combined Emphysema and Pulmonary Fibrosis) in 
IPF human patients. Addition of SP-C to cholesterol-laden lipid vesicles enhanced the expression of 
cholesterol metabolism and transport genes in an alveolar macrophage cell line, identifying a potential new 
lipid-protein axis involved in lung remodeling.
Keywords: surfactant protein C, pulmonary fibrosis, alveolar dynamics, lung structure, alveolar 
homeostasis, lipid metabolism, alveolar macrophages 
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Introduction
Idiopathic pulmonary fibrosis (IPF) is a chronic progredient, restrictive interstitial lung disease (ILD), 
characterized by increased collagen deposition with fatal outcome. Current pathogenetic concepts focus on 
the dysfunction of alveolar epithelial type 2 cells (AEC2), stem cell exhaustion and aberrant profibrotic 
wound repair (1). On high resolution computer tomography (HRCT) images, IPF depicts the picture of 
usual interstitial pneumonia (UIP), characterized by the presence of heterogeneously distributed 
honeycomb cysts with basal and subpleural predominance (2–4). 2-20% of IPF patients present with a 
positive familial history classified as familial pulmonary fibrosis (FPF) (5–8). Multiple gene studies have 
identified a wide set of genes that seem to drive fibrogenesis (9–12), including mutations of genes encoding 
surfactant proteins (7, 13–16). 
Pulmonary surfactant mainly consists of phospholipids (PL) and surfactant proteins A, B, C and D. 
SP-B and SP-C are essential for reducing surface tension at the alveolar air-liquid interface (17, 18). The 
hydrophobic, mature SP-C peptide has been shown to be crucial for maintaining surfactant homeostasis 
under dynamic conditions. During surfactant film compression, SP-C provides film stability at low lung 
volumes (17, 19, 20). As the respiratory cycle progresses, SP-C facilitates the re-incorporation of sub-
interfacial phospholipids into the monolayer, promoting film expansion upon inspiration (17, 18, 21). To 
date more than 60 different mutations in the human SFTPC gene have been associated with development 
of acute and chronic lung disease in infants, children and adults (22–24). The SFTPC gene is exclusively 
expressed by AEC2 and encodes the 21kDa precursor protein proSP-C (25, 26).
Aging is one of the main common factors in IPF mainly affecting patients exceeding the age of 60 (2). 
With increasing age the lung is progressively challenged with harmful biological and physical noxae (27–
29). Multiple hits such as repeated exposure to mechanical stress, as occurs during heterogenous lung 
ventilation in the setting of increased surface tension and alveolar instability, were further shown to 
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compromise AEC2 integrity (30–33). Aging lungs themselves show a trend towards increasing lung 
stiffness and lower compliance in combination with lower surfactant volumes that, in turn, may contribute 
to impaired lung function in the elderly (34, 35). 
In addition, impaired lipid metabolism is related to many different lung diseases including pulmonary 
alveolar proteinosis (PAP) and lung fibrosis. Reduced lipid metabolism has been related to endoplasmic 
reticulum (ER) stress (36) and as communication axis between AE2C and alveolar macrophages (37) leading 
to fibrotic remodeling. Even though limited information in the exact mechanisms of regulation of lipid 
metabolism, and more specifically cholesterol metabolism, exits (38), it may present a new therapeutic 
target in lung fibrosis (39).
In the current study, we aim to elucidate the role of SP-C in the development of spontaneous lung 
fibrosis as well as the ordering of the events leading to fibrotic remodeling in the absence of this protein. 
For this, we studied the alveolar dynamics, lung structure and function of SP-C KO mice during 60 weeks 




SP-C deficient mice, bred on the 129Sv background, were introduced before (40) and obtained with 
permission from Cincinnati children’s hospital (Cincinnati, Ohio). 129Sv healthy mice, which served as 
control group, were acquired from Charles River GmbH (Sulzfeld, Germany). Details about the animal 
groups is stated in supplementary methods.
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Lung mechanic and function measurements 
All animals were weighed and anesthetized via intraperitoneal injection of 80mg/kg ketamine and 
5mg/kg xylazine in 0.9% sodium chloride. Following tracheotomy, mice were connected to a small animal 
ventilator (FlexiVent, SCIREQ, Montreal, QC, Canada). Mechanical ventilation was performed as described 
previously (41) and detailed in supplementary methods. Oxygen saturation in percentage of functional 
arterial hemoglobin was determined during normal mechanical ventilation at PEEP 3cmH2O with the use 
of a rodent oximeter (MouseOx Plus, Starr Life Sciences Corp., US). Afterwards vascular perfusion-fixation 
was performed as explained in supplementary methods.
Histological sections and staining
Tissue slices were embedded into hydroxyethylmethacrylate (Technovit 8100, Kulzer Heraeus, 
Wehrheim, Germany). For further design-based stereology on light microscope level, tissue sections were 
stained with toluidine blue as detailed in supplementary methods. Simultaneously, lung cubes were 
sampled randomly for representative electron microscope (EM) imaging as explained in supplementary 
methods. Remaining tissue slices were embedded in paraffin and stained with a Masson-Goldner staining 
kit (Merck, Darmstadt, Germany). Immunostaining of human tissue sections is detailed in supplementary 
methods.
Design-based stereology
Design-based stereology is the gold-standard for quantitative lung structure analysis based on 
histological images enabling profound mathematical inference from 2D sections about 3D geometrical 
bodies, as which microarchitectural compartments of the distal lung have to be considered (42). All 
analyzed parameters for lung structure regarding fibrosis were chosen according to recommendations from 
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Ochs and Mühlfeld (43) for stereology in pulmonary fibrosis. A detailed description of investigated 
parameters and corresponding test systems is presented in table 1 and supplementary methods. 
Hydroxyproline assay
Hydroxyproline content was measured in accordance to the protocol established by Reddy and 
Enwemeka (44) and detailed in supplementary methods. 
Real time - PCR
RNA was isolated from homogenized, post-lavage lungs following ISOLATE II RNA Mini Kit 
instructions (ISOLATE RNA Mini Kit, Bioline GmbH, Luckenwalde, Germany). cDNA synthesis was 
performed in a Thermal Cycler (CFX96TM, Bio-Rad Laboratories, Munich, Germany). Subsequent RT-PCR 
was performed with iTaq Universal SYBR Green Supermix (Bio-Rad Laboratories, Munich, Germany), 
primer sequences are shown in detail in table 2 and detailed in supplementary methods. 
Cholesterol assay
Total cholesterol concentration was quantified following instructions of Total Cholesterol Assay Kit 
(Colorimetric) (Cell Biolabs, Inc., San Diego, CA 92126) as explained in supplementary methods. 
Engulfment of cholesterol-laden lipid vesicles with or without SP-C
Uptake of cholesterol-laden with/without SP-C lipid vesicles by alveolar macrophages was performed 
using a fluorescently label cholesterol probe and quantified as the percentage of cells presenting 
fluorescence in a flow cytometer. Further details can be found in supplementary methods. 
Statistical analysis
Graphs and statistical analysis were conducted with GraphPad Prism 6.0 (GraphPad Software, San 
Diego, CA, USA) and detailed in supplementary methods.
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Results
Impaired alveolar recruitment is accompanied by increased tissue stiffness in the lungs of SP-C KO 
mice
Body weight (BW) gain was significantly delayed in SP-C KO mice in comparison to healthy 129Sv mice 
up to an age of 40 weeks (Figure 1A). Likewise, absolute lung volume was significantly reduced at early 
ages (10 and 20 weeks) (Figure 1B). Simultaneously, inspiratory capacity (IC) was significantly reduced at 
an age of 10 and 20 weeks in comparison to healthy mice (Figure 1C). Accordingly, static compliance (Cst) 
(Figure 1D) was significantly reduced in comparison to age-matched healthy 129Sv mice. 
Tissue elastance (H) was assessed at positive end-expiratory pressure (PEEP) of 1cmH2O, 3cmH2O and 
6cmH2O as an indicator of distal parenchymal stiffness (Figure 1E). At the early age of 10 and 20 weeks, 
lungs of SP-C KO mice exhibited significantly increased tissue elastance compared to healthy controls at 
every applied PEEP (Figure 1F-H) pointing at stiffer lungs in the absence of SP-C at early ages. Increasing 
airway pressure from 1 to 6 cmH2O may facilitate alveolar recruitment, resulting in reduced tissue stiffness, 
as seen in healthy 129Sv mice (Suppl. Figure 1A). However, an applied PEEP of 6cmH2O (Figure 1E) failed 
to further reduce tissue elastance at the ages of 10, 50 and 60 weeks, compared to low pressure such as 
PEEP of 3cmH2O in the SP-C KO group. This pointed at reduced recruitability of alveolar spaces at older 
ages (either due to alveolar collapse, permanent de-recruitment and/or a remodeling process) as a result of 
SP-C deficiency during an abnormal lung aging. In addition, a mixed-effects statistical analysis revealed 
that changes were mostly an effect of both genotype and aging (Suppl. Table 3)
Accordingly, tissue damping (G), assessed at PEEP of 3cmH2O, significantly decreased from week 20 
to week 30 in the SP-C KO group, while healthy mice showed no age-dependent alterations in G (Figure 
1I). Meanwhile, tissue hysteresivity (η) of SP-C KO mice exhibited only minor fluctuations in contrast to 
healthy controls displaying a continuous increase until 50 weeks of age (Figure 1J). Thus, significant 
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differences between both groups were found at an age of 10 and 40 weeks, suggesting altered rheological 
properties of the lung tissue. However, the main effect was due to age and not genotype (Suppl. Table 3).
Stereological analysis revealed an increased volume fraction (Vv) of non-ventilated parenchyma in the 
SP-C KO group in comparison to healthy mice, which was significant at an age of 20, 40, 50 and 60 weeks 
(Figure 1K). Taken together, deficiency of SP-C resulted in loss of ability on reopening alveoli at higher 
pressure and abnormal rheological properties of the lung tissue, pointing at an ongoing remodeling 
process. In addition, a mixed-effects statistical analysis revealed the absence of SP-C as major contributor 
to the decrease of ventilated parenchyma and the increase of non-ventilated parenchyma (Supp. Table 3)
Ductal airspace overdistension precedes septal thickening in the SP-C KO lung 
General lung morphology during aging can be observed in figure 2A. SP-C KO lungs exhibited a slight 
age-dependent decrease in alveolar space volume fraction (Vv(alv/par)) meanwhile an increase in ductal 
airspace volume fraction (Vv(duct/par), which became significant at 50 weeks of age (Figure 2B and 2C). 
Accordingly, mean linear intercept length measurements were not significantly changed in SP-C KO versus 
healthy 129Sv mice, except at 50 weeks of age (Figure 2D). Healthy 129Sv mice lungs did not reveal a major 
trend towards an increasing or decreasing Vv(alv/par) (Figure 2B). In addition, volume weighted mean 
volume (ῡv(alv)) values varied around the baseline observed at 10 weeks (Figure 2E) for healthy controls. 
In contrast, ῡv(alv) remained unaltered over the first 20 weeks in the SP-C KO group, but exhibited a 
significant increase at the end of week 30 (Figure 2E), indicating a rearrangement in the alveolar 
architecture and increased alveolar size heterogeneity. 
Alveolar epithelial surface (S(alvepi)) was significantly reduced at 20 and 50 weeks in contrast to 
healthy mice (Figure 2F). In line with lung volume development, alveolar surface rose significantly in the 
lungs of 30-week-old SP-C KO animals, but tended to decline from week 30 to week 50 (Figure 2F). 
Simultaneously, septal thickness steadily decreased until week 40, where a tendency towards thicker 
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alveolar septa was observed (Figure 2G). Accordingly, SP-C KO mice lungs showed significantly thicker 
septal walls, in head-to-head comparison with their healthy counterparts at an age of 50 weeks (Figure 2G). 
Significantly, increased thickness from week 50, coincided with the appearance of consolidated lesions, 
giving the first indication of fibrotic remodeling (Figure 2A; micrographs 10 and 12). In addition, over 
distended ductal airspaces corresponding to increased ductal airspace volume fraction became particularly 
prominent in subpleural regions (Figure 2A; micrographs 3, 5 and 7). These features were not observed in 
healthy control lungs (Suppl. Figure 2A).
SP-C KO mice lungs exhibit altered tissue composition and aberrant connective-tissue protein gene 
expression 
Masson´s-Goldner trichrome staining provided further insight into tissue composition of observed 
microscopic wounds, most prominently in the lungs of 50 and 60 weeks of age. While thickness of septa 
was not accompanied by staining for collagen from week 10 to week 20, consolidations in parenchyma 
stained positive for collagen at the age of 50 and 60 weeks (green, Figure 3A), especially in comparison to 
older healthy mice (Suppl. Figure 3A). Therefore, increased septal thickness at early ages seemed to arise 
from alveolar collapse, while the later onset of thickening was associated with interstitial collagen 
deposition. Quantification of hydroxyproline showed a tendency towards higher levels with age but did 
not demonstrate significant differences between age cohorts or genotypes (Figure 3B and Suppl. Figure 3B). 
Relative Col1a1, Col3a1 and Fn expression obtained from RT-PCR analysis was significantly downregulated 
in the SP-C KO mice over age (Figures 3C, 3D and 3F). Likewise, Col2a1 and Eln also tended towards lower 
expression levels but were not significantly different (Figure 3F and 3G). This represents a different, 
aberrant remodeling of fibers in comparison with the normal re-distribution of fibers in healthy aging mice 
(Suppl. Figure 3C-3G).
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SP-C deficiency alters the innate immune system of the lung
The total number of cells in BAL of the SP-C KO cohort declined with age (Figure 4A). In contrast, the 
number of cells counted in healthy BAL remained constant at a generally lower level than in BAL recovered 
from SP-C KO mice (Figure 4A). Statistical analysis revealed significant differences between healthy and 
SP-C KO at 10 and 20 weeks of age and the effect seemed to be mainly due to the genotype and not age 
(Supp. Table 3). Light microscopic analysis of immune cell subtypes identified macrophages as the 
predominant cell type with a minor but constant fraction of neutrophils in the healthy mice independent 
of age (Figure 4B and Suppl. Figure 4A). In contrast, the proportion of neutrophils was increased in SP-C 
KO mice at 40 weeks of age and was accompanied by the appearance of eosinophils at week 50.
Fibrotic areas of a lung section validated the presence of electron-dense clefts in IPF lung tissue (Figure 
4C). Further, ultrastructural phenotype qualitative analysis of lung macrophages was performed in the SP-
C KO mice for every age group. At 10 and 20 weeks of age, macrophages derived from SP-C KO lungs 
exhibited numerous electron-dense, lamellar-body-like, inclusions in the cytoplasmic cell compartment. In 
the successive 10 weeks, the cells further accumulated these inclusions and appeared loaded with various 
electron-dense clefts (Figure 4D, micrographs 7-12). Meanwhile, healthy control mice of the same strain did 
not show any cleft accumulation over the entire study frame (data not shown). EM micrographs of AEC2 
showed no morphological alterations. 
Absence of SP-C leads to impaired cholesterol metabolism in alveolar macrophages
Due to the notable appearance of electron-dense inclusions only in the alveolar macrophages of SP-C 
KO lungs, we investigated the cholesterol metabolism in these cells. Expression of cholesterol efflux 
transporters, such as ATP binding cassette A1 (Abca1) and G1 (Abcg1), as well as regulatory elements of the 
metabolism of cholesterol, such as the gene encoding the low-density lipoprotein (Ldlr) receptor, the liver 
x receptor alpha (Lxra), the cholesterol-25-hydroxlyase (Ch25h) and the sterol-response element binding 
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protein 2 (Srebp2) steadily increased over the first 30 weeks (Figure 5A). In addition, their expression 
significantly dropped from week 30 to 40 and was hardly detectable at 50 and 60 weeks. At the same time, 
total cholesterol amounts relative to total lung tissue exhibited a significant and constant increase (Figure 
5B) with advancing age, as well as for the healthy 129Sv mice. In addition, the mixed-effect statistical 
analysis revealed that age was the main contributor to the changes in total cholesterol (Suppl. Table 3).
Interestingly, expression rates of cholesterol related genes were mirrored by gene expression of 
macrophage activator chitinase-like-3 (Ym1) (Figure 5A). In contrast, slight changes in gene expression of 
BAL cells from healthy animals were observed (Suppl. Figure 5A). In vitro, engulfment ability of 
macrophages from SP-C KO BAL was reduced when exposed to lipid, cholesterol-laden lipid and SP-C-
laden lipid vesicles compared to WT macrophages (Figure 5C). However, the addition of both cholesterol 
and SP-C to the lipid vesicles increased the uptake up to control conditions (SP-C KO macrophages exposed 
to lipid vesicles) and to their WT counterpart for this condition (WT macrophages exposed to cholesterol + 
SP-C-laden lipid vesicles). In addition, we analyzed the uptake of a mouse macrophage cell line, MHS-C in 
its ability to uptake lipid vesicles with/without cholesterol and/or SP-C (Figure 5D) and changes in 
cholesterol metabolism and transport gene expression (Figure 5E, 5F and 5G). Interestingly, the addition of 
SP-C to the cholesterol-laden vesicles increased not only the uptake but also further activated genes for 
cholesterol metabolism and transport (such as Pparg, SraI, Abca1, Abcg1, Lxrb and Srebp2).
Structure-function relationship in the aging SP-C KO lung
Peripheral arterial oxygen saturation (SpO2) level was progressively reduced at older ages. Meanwhile, 
SpO2 in control mice remained unimpaired up to the age of 60 weeks (Figure 6A). In addition, the mixed-
effect statistical analysis revealed that the genotype (group) was the main contributor to these changes 
(Suppl. Table 3). µCT imaging of a 60-week-old male SP-C KO mice showed multiple subpleural areas of 
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consolidated lung tissue (Figure 6B). Similarly, an analogous thoracic HR-CT image of a 75-year-old IPF 
patient exhibited subpleural reticular septal thickening adjacent to cystic airspace enlargement (Figure 6C). 
Over the whole study, increasing fractions of non-ventilated parenchyma correlated with loss of 
alveolar surface at the light microscopic level (r=-0,455, p=0,001) (Figure 6D). Furthermore, absolute lung 
volume and surface density exhibited an inverse relationship (r=-0,445, p=0,001) (Figure 6G). Rising 
inspiratory capacity correlated significantly with an increase in ductal airspace volume fraction (r=0,292, 
p=0,039) (Figure 6E). Increase in tissue damping was significantly proportional to rising septal thickness 
(r=0,290, p=0,044) (Figure 6F), indicating pronounced tissue rigidity in thickened interalveolar septa. 
Simultaneously, a negative correlation was found between septal thickness and the fraction of ventilated 
parenchyma (r=-0,532, p<0,001) (Figure 6I). A summary of correlation statistics is provided in Table 2.
Discussion
Over a 60 weeks period both adaptive and compensatory mechanisms may be activated to facilitate 
the main function of the lung, gas exchange, in SP-C deficient mice. These mice suffered a mild decline in 
lung function, with reduced SpO2 values (Figure 6A) during re-organization of air-spaces, but weeks before 
fibrotic wounds were detected. Similarly, it could be hypothesized that human patients with IPF may 
undergo re-arrangement of air-spaces years before symptoms appear and they are diagnosed. This animal 
model was first developed and described by Glasser and colleagues (19). They demonstrated altered 
stability of lung surfactant activity from SP-C-/- mice compared to SP-C+/+ mice, especially at low bubble 
volumes (in vitro) and low lung volumes (in vivo). It has already been described that SP-C is critical for the 
stability of the lipid surfactant film at the interface (17, 45), the lack of this protein may lead to collapse of 
small alveoli. 
Interestingly, it has been reported that SP-C KO mice did not have any histological differences to their 
WT counterparts at the embryonal age of 18.5 and postnatal day 1 (40). However, we could observed lungs 
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of 10 weeks mice showing typically thickened septal walls and shortened alveolar septal tips suggesting a 
delay development, which seems to be normalized at the age of 20 weeks (Figure 2A). In addition, higher 
expression of the collagen genes in this group also points at an ongoing delayed development of the lung 
(Figure 3C-D). Interestingly, those 10 weeks lungs contain also a higher number of BAL cells (mainly 
macrophages (Figure 4A and 4B)) pointing at an abnormal postnatal innate immune system. It may be 
possible that SP-C does not play an important role during prenatal development, but it does at the moment 
air enters the lung for the first time and during the first weeks of postnatal development. This suggests that 
without SP-C, a newly air-breathing lung may suffer from alveolar instability and collapse (we could detect 
higher volume densities of non-ventilated parenchyma in the KO mice at 10 weeks (Figure 1K)) due to lung 
surfactant instability. This instability during compression (expiration) of the alveolar surface may lead to 
abnormal mechanical and physical forces (19, 23, 26). This may delay the normal postnatal development of 
the lung until the 10th week of life, when we analyzed our animals. In addition, other animal models, 
showing SP-C deficiency, have reported abnormal lung development (46, 47). However, since a complete 
analysis of pre- and postnatal lung development in these mice is missing, we could only speculate about 
the potential role of SP-C on these processes.
Alveoli seemed to be recruited with high pressure (such as PEEP 6cmH2O) in normal healthy animals, 
but somehow recruitment is impaired in older SP-C KO mice (Figure 1E). Therefore, these results suggest 
that chronic alveolar instability seemed to lead to permanent de-recruitability of alveoli in 50- and 60-weeks 
old SP-C KO mice. This permanent de-recruitment leads to changes in H (tissue elastance) and G (tissue 
damping) with age resulting in differences in  at the age of 60 weeks. Differences in H and G towards 
progressive loss of elastance and tissue damping have also been described in the elastase-induced 
emphysema mouse model (48) accompanied by an increase in . Increases in  were also related to 
increased heterogeneity throughout the lung (49) in complex disease phenotypes. Therefore, the evidences 
from this study suggests a complex disease phenotype where over-expansion (emphysema-like phenotype) 
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of air spaces and consolidated collapsed (de-recruited alveoli) regions co-exist within the lungs of SP-C KO 
mice. These results are supported by the lung micrographs in figure 2A and suggest that over-distension 
of ductal and alveolar spaces precedes the consolidation of lung tissue starting at week 40 of age. In 
addition, septal wall thickness tended to increase in the 40 to 60-week groups (Figure 2G). These changes 
were not statistically significant mainly due to the increasing heterogeneity in the lungs (50). Moreover, 
although fibrotic alterations have been repeatedly linked to elevated lung stiffness, elastance in a 
pulmonary spring model only substantially increased once a certain percolation threshold was reached 
(51). Projected on the SP-C KO lung, these findings may explain why H showed only subtle increases at 60 
weeks of age, despite the presence of multiple fibrotic lesions.
Further analysis of the septal wall composition confirmed the slight increase in collagen production at 
both the protein (Figure 3B) and mRNA (Figure 3C-3G) levels. As stated previously, pronounced 
phenotypic heterogeneity, with over distended air spaces and aberrant wound healing, masks statistically 
significant differences. However, this heterogeneity itself is a common feature and resembles human 
samples of patients suffering IPF, as shown in the HRCT scans in figure 6B and 6C.
During the 60 weeks of the study, we did not observe any sign of edema or inflammation. In addition, 
the total number of BAL cells in aging SP-C KO mice decreased progressively reaching the number of cells 
in healthy controls (Figure 4A). Analyzing the types of cells in BAL, we discovered some infiltrating cells 
in older lungs. At 40 weeks of age, neutrophils appeared in the BAL samples, but in a moderate proportion 
(less than 10%). This proportion increased further in the 50-week group, and eosinophils appeared, but 
again in a moderate proportion, not enough to suspect pulmonary inflammation or lung injury (Figure 4B). 
Therefore, the findings of this study suggest that these infiltrating cells may contribute to the remodeling 
of the tissue rather than a response to inflammation or infection. This assumption is supported by previous 
reports where both infiltrating cell types have been related to remodeling processes in the lung (47, 52–54). 
In addition, and noteworthy, are the changes in morphology of alveolar macrophages in the aging SP-C 
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KO mice in accordance with findings in IPF patient samples (Figure 4C). As briefly described before (40), 
macrophages of SP-C KO mice contain electron dense crystals in their cytoplasm (Figure 4D). Crystals were 
first detected in animals at 30 weeks of age. While in human patients this may be a hallmark of an 
eosinophilic pneumonia, in some cases associated with pulmonary fibrosis (55), the appearance of crystals 
before the infiltration of eosinophils, or any other infiltrating cell as well as any sign of fibrotic remodeling 
in the SP-C KO lungs, discards the hypothesis. On the one hand, those crystals are similar to cholesterol 
crystals seen in macrophages throughout the literature in the presence of cholesterol (56–59). The 129Sv 
strain exhibits abnormal absorption of dietary cholesterol (60) and is widely used in the study of cholesterol 
metabolism. Besides, this macrophage phenotype has not been described in other SP-C KO strains, with 
BALBc or B6N background. We observed a notable increase in cholesterol in the lung tissue of the SP-C KO 
mice from the 30 weeks of age (Figure 5B). However, the same pattern was also observed for their healthy 
controls’ counterparts (Figure 5B) but crystals were not found in alveolar macrophages. In this regard, 
Romero and colleagues (61) showed increased amounts of cholesterol in lung tissue of mice after bleomycin 
treatment and attributed this to paracrine lipid cross-talk between alveolar epithelial cells and alveolar 
macrophages. Thus, initial observations reported here suggest that this cross-talk may be impaired in the 
absence of SP-C, in our model. Other lipid transporters have also been reported to be involved in 
development of fibrosis, including ApoE, ApoA1 and ABCG1 (62–65). Interestingly gene expression of 
cholesterol metabolism and transport genes showed a biphasic behavior as well as cholesterol content in 
the lung. When the genes under study are down-regulated, cholesterol started accumulating in the lung, 
right at week 30, where the first crystals appear under electron microscopy (Figure 4F, 5A and 5B). In 
addition, in vitro experiments supplementing cholesterol-laden lipid vesicles with SP-C enhanced not only 
the uptake of those vesicles by MH-S, but also resulted in an increased expression of genes related to 
cholesterol metabolism and transport (such as Pparg, SraI, Abca1, Abcg1, Lxrb and Srebp2). This support the 
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assumption that enhanced metabolism and mobilization of cholesterol in alveolar macrophages may be 
regulated by SP-C in alveolar macrophages.
Cholesterol metabolism has not been deeply studied in lung fibrosis patients. Nowadays there is 
growing evidence that lipid metabolism is impaired in lung fibrosis (36, 37, 66), but there is no data specific 
regarding to cholesterol. Interestingly, it is not very surprising that with the average age of IPF patients, 
around 60 years old, many of them suffer from co-morbidities such as hypercholesterolemia. Kreuter and 
colleages published some interesting analysis (67–69) on the potential effect of the uptake of statins during 
the treatment of IPF with Nintedanib. Even though there is much controversy around it, they concluded 
that patients under treatment of statins and Nintedanib showed a slower/delayed loss of FEV, pointing at 
a potential beneficial effect of the lowering down cholesterol during treatment of IPF. No pre-clinical data 
is found about this effect yet in the literature, so we could only speculate on the effect of cholesterol in the 
progression of the disease. Nevertheless, this opens a new field of research in the future and new 
therapeutic strategies, which should first undergo pre-clinical studies.
In conclusion, the findings of this study suggest that overall loss of SP-C results in an age-dependent 
complex, heterogeneous phenotype characterized by a combination of overdistended air spaces and fibrotic 
wounds that resembles CPFE (Combined Pulmonary Fibrosis and Emphysema) in IPF human patients. 
Interestingly, this remarkable phenotype is unique to the 129Sv strain, which was previously shown to 
have an increased absorption of cholesterol, thus linking the accumulation of cholesterol and the absence 
of SP-C to a fibrotic remodeling process. Besides, addition of SP-C to cholesterol-laden lipid vesicles 
enhanced the expression of cholesterol metabolism and transport genes in alveolar macrophages, pointing 
towards a new lipid-protein axis involved in lung remodeling.
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Figure legends
Figure 1. Impaired alveolar recruitment is accompanied by increased tissue stiffness in the lungs of SP-
C KO and healthy 129Sv mice. A) Body weight (BW); B) Lung volume (ml); C) Inspiratory capacity (IC); 
and D) Static Compliance (Cst) over time. E) Tissue elastance (H) as indicator of distal lung tissue stiffness 
was obtained during forced oscillation technique and calculated according to the constant phase model at 
PEEP 1cmH2O (black bars), 3cmH2O (grey bars) and 6cmH2O (white bars) for each age group, respectively, 
n≥ 8 (black horizontal lines indicate statistically significant differences between the groups they connect 
p<0.05). F) tissue damping (G); and G) tissue hysteresivity (𝜂) were assessed at 10-60 weeks of age. H) 
Volume fraction (Vv) of ventilated parenchyma (light grey) and non-ventilated parenchyma (white) within 
lung parenchyma of SP-C KO mice at different ages. Mean ± SD, n≥6; horizontal black lines with an asterisk 
(*) represents a statistical difference p<0.05 between SP-C KO vs Healthy within age groups. Statistical 
differences over age are represented in blue for the SP-C KO group and in grey for the healthy controls. 
+p<0.05 vs. 10 weeks; #p<0.05 vs. 20 weeks; §p<0.05 vs. 30 weeks; <p<0.05 vs. 40 weeks.
Figure 2. Ductal airspace over distension precedes septal thickening in the SP-C KO and healthy 129Sv 
lung. A) Representative Toluidine-blue stained micrographs of vascular perfused-fixed murine SP-C KO 
lungs (inflated with air at airway pressure = 5cmH2O), revealed thickened interalveolar septa as marker of 
microatelectasis (pink arrow) (A1-2). This was followed by alveo-ductal over distension (green arrow), 
which coincidences with alveolar size reduction in the same topographic region at an age of 20 weeks (A3-
4). This process was found to further develop until week 30 (A5-6), predominating in the subpleural regions 
(A3, A5). At 40 weeks of age enlarged alveolar ducts localized next to prominent septal walls (arrowhead) 
(A7, A8). 10 weeks later first fibrotic lesions (yellow arrow) appeared causing tensile stress of the 
surrounding lung parenchyma (A9-10). After 60 weeks, septal wall thickening progressed, while alveolar 
destabilization in sense of collapse induration continued (A11-12). Age-dependent lung structure analysis 
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of: B) alveolar airspaces density (Vv(alv/par)); C) ductal airspaces density (Vv(duct/par); D) mean linear 
intercept length; E) Mean volume weighted mean volume (ῡv(alv)); F) absolute surface of the alveolar 
epithelium (S(alvepi)); and G) Septal wall thickness (µm) were quantified within the ventilated parenchyma 
(V(vent-par, lung) over age. Mean ± SD, n≥6; horizontal black lines with an asterisk (*) represents a statistical 
difference p<0.05 between SP-C KO vs Healthy within age groups. Statistical differences over age are 
represented in blue for the SP-C KO group and in grey for the healthy controls. +p<0.05 vs. 10 weeks; #p<0.05 
vs. 20 weeks; §p<0.05 vs. 30 weeks; <p<0.05 vs. 40 weeks.
Figure 3. SP-C KO mice exhibit altered tissue composition and aberrant connective-tissue protein gene 
expression. A) Masson-Goldner trichrome staining over age, showed the abundance of dense, non-
ventilated parenchyma areas at 10 and 50 weeks of age. At 50 weeks these lesions (arrow) were interspersed 
with collagen (green), while no collagen deposition was visible lungs from 10-week-old mice (arrowhead). 
B) Hydroxyproline level was quantified in representative tissue sections at 40, 50 and 60 weeks (*p<0.05, 
n=5) and; C-G) RT-PCR gene expression analysis of collagen 1a1, collagen 1a2, collagen 3a1, elastin and 
fibronectin in healthy and SP-C KO lungs at the ages of 10-60 weeks showed decreasing expression levels 
becoming significant for Fn, Col1a1 and Col3a1. Normalized by Gapdh; +p<0.05 vs. 10 weeks, n=5.
Figure 4. SP-C deficiency alters the innate immune system of the lung. A) Total BALF cell count assessed 
in SP-C KO and healthy 129Sv mice. B) Relative quantification of leukocyte subpopulations in BALF cells 
of SP-C KO mice. C) Electron-microscopic micrograph of an IPF lung demonstrates the presence of intra-
parenchymal macrophages being loaded with electron-dense crystals (pink arrow). D) Representative 
electron-microscopic imaging of SP-C KO lungs over age demonstrates unaltered AEC2 morphology with 
physiologically shaped lamellar bodies (green arrow) (F1-6) and electron-dense intracellular inclusions 
with cleft formation in lung macrophages (pink arrow) (F7-12). Onset of crystal formation starts at 30 weeks 
of age. Detailed structural morphology of the lamellar-body-like inclusions and electron-dense clefts is 
provided on high-magnification micrographs (F13-18). Mean ± SD, n≥6; horizontal black lines with an 
Page 31 of 64  AJRCMB Articles in Press. Published on 10-January-2020 as 10.1165/rcmb.2019-0358OC 
 Copyright © 2020 by the American Thoracic Society 
asterisk (*) represents a statistical difference p<0.05 between SP-C KO vs Healthy within age groups. 
Statistical differences over age are represented in blue for the SP-C KO group and in grey for the healthy 
controls. +p<0.05 vs. 10 weeks.
Figure 5. Absence of SP-C leads to impaired cholesterol metabolism in alveolar macrophages. A) RT-
PCR gene expression analysis of ATP binding cassette A1 (Abca1), ATP binding cassette G1 (Abcg1), 
cholesterol-25-hydroxylase (Ch25h), LDL receptor (Ldlr), liver X receptor alpha (Lxra), sterol response 
element binding protein 2 (Srebp2) and chitinase like 3 or Ym1 (Chil3) in BALF cells. Normalized by Gapdh. 
B) Total Cholesterol quantification in SP-C KO and healthy 129Sv lungs per µg lung tissue at week 10-60. 
C) Fluorescent-lipid uptake by alveolar macrophages as percentage of engulfment, measure by FACS 
detection of fluorescent BAL cells from WT or SP-C KO mice. Macrophages were exposed to 0.25µg of 
labeled phospholipid per 105 cells, with/without cholesterol and/or SP-C. Black horizontal lines represents 
p<0.05 between WT vs KO using a t-test, light blue horizontal lines represents p<0.05 when comparing 
different vesicle composition within the SP-C KO group using an ANOVA. D) MH-S cells, alveolar 
macrophage-like mouse cell line, were exposed to lipid vesicles laden with fluorescent cholesterol and/or 
SP-C and lipid uptake was measure in FACS as explained before. E) In another set of experiments 
macrophages exposed to vesicles with different composition during 1 h were collected for RNA isolation 
and RT-PCR analysis of expression of genes related to cholesterol metabolism and transport. F) 
Representative heat map of relative expression of the different genes using clustering by targets (right) and 
samples ordered by type (top). The green rectangle shows different targets up-regulated in the samples 
containing cholesterol and SP-C in comparison to samples containing only cholesterol or SP-C. G) Relative 
gene expression (ΔΔCq, normalized by Actb) in the different samples (n=6 per group) of the most interesting 
upregulated genes from the heat map, Pparg, SraI, Abca1, Lxrb, Abcg1, and Srebp2). Mean ± SD, n≥6; 
horizontal black lines with an asterisk (*) represents a statistical difference p<0.05 between SP-C KO vs 
Healthy within age groups. Statistical differences over age are represented in blue for the SP-C KO group 
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and in grey for the healthy controls. +p<0.05 vs. 10 weeks; #p<0.05 vs. 20 weeks; §p<0.05 vs. 30 weeks; 
<p<0.05 vs. 40 weeks; >p<0.05 vs. 50 weeks.
Figure 6. Structure-function relationship in the SP-C KO lung. A) Peripheral arterial oxygen saturation 
(SpO2) was measured at PEEP 3cmH2O before subsequent ventilation protocol was started in SP-C KO and 
healthy 129Sv mice; B) µCT imaging of a fixed SP-C KO lung shows distinct parenchymal lesions 
predominating in the subpleural compartments (pink arrow); C) HR-CT imaging of a 75-year-old IPF 
patient. The pathology impresses with reticular septal thickening, honeycomb-cysts, traction 
bronchiectasis, and tissue consolidation (pink arrow) in the means of UIP pattern. The pathology 
predominates in the subpleural regions and localizes in the direct neighborhood of over distended lung 
parenchyma. Statistically significant correlation of structural and mechanical parameters over the whole 
study period (● 10 weeks, ■ 20 weeks, ▲ 30 weeks, ▼ 40 weeks, ◆ 50 weeks, ○ 60 weeks). D) Negative 
correlations between alveolar surface and non-ventilated parenchyma volume fraction by stereological 
analysis, and E) surface density and absolute lung volume. F) Proportional relationship of ductal volume 
fraction and inspiratory capacity acquired by FlexiVent. G) Positive correlation of mean linear intercept and 
absolute lung volume as independently determined structural parameters. H) Tissue damping and septal 
thickness exhibit a positive structure-function relationship whereas I) ventilated parenchyma volume 
fraction and septal thickness correlate inversely. Mean ± SD, n≥6; horizontal black lines with an asterisk (*) 
represents a statistical difference p<0.05 between SP-C KO vs Healthy within age groups.
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Tables
Table 1 Absolute volumes of lung compartments determined by design-based stereology in SP-C KO mice 
lungs. Absolute stereological lung volumes (mL) are given with mean and standard deviation (SD) for every 
age group. V(par, lung)=absolute lung parenchyma volume; V(non-par, lung)=absolute non-parenchyma 
volume; V(vent-par, lung)=absolute ventilated parenchyma volume; V(non-vent-par, lung)=absolute non-
ventilated parenchyma volume; V(alv, lung)=absolute alveolar space volume; V(duct, lung)=Absolute 
ductal airspace volume; V(sept, lung)=absolute septal volume.
Table 2 Statistically significant correlations following Spearman test and linear regression comprising all 
SP-C KO age cohorts.
10 weeks 20 weeks 30 weeks 40 weeks 50 weeks 60 weeks
Parameter [ml] Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
V(par/lung) 0.34 0.07 0.35 0.05 0.63 0.11 0.42 0.07 0.53 0.10 0.49 0.10
V(non-par/lung) 0.05 0.02 0.06 0.02 0.09 0.02 0.05 0.01 0.07 0.02 0.08 0.03
V(vent-
par/lung)
0.33 0.07 0.34 0.04 0.62 0.10 0.42 0.07 0.51 0.10 0.48 0.10
V(non-vent-
par/lung)
0.008 0.006 0.009 0.004 0.010 0.006 0.006 0.003 0.013 0.006 0.010 0.006
V(alv/lung) 0.16 0.04 0.15 0.02 0.29 0.05 0.19 0.03 0.21 0.03 0.22 0.06
V(duct/lung) 0.13 0.05 0.15 0.03 0.27 0.05 0.20 0.04 0.26 0.07 0.22 0.04
V(sept/lung) 0.04 0.01 0.04 0.05 0.07 0.11 0.04 0.01 0.05 0.01 0.06 0.01
Correlating parameters Spearman - r Spearman - 
Sig. two-sided
N Linear regression
Vv(non-vent-par/par), S(alvepi,lung) -0.455** 0.001 51 Y = -1974*X + 260.7
Lung volume, Sv -0.445** 0.001 51 Y = -0.02113*X + 0.06102
IC, Vv(duct/par) 0.292* 0.039 50 Y = 0.1339*X + 0.3125
Lung volume, Mean linear intercept 0.495** 0.000 51 Y = 37.91*X + 52.61
Septal thickness, G 0.290* 0.044 49 Y = 0.2579*X + 2.990
Septal thickness, Vv(vent-par,par) -0.532** 0.000 51 Y = -0.02671*X + 0.5584
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Figure 1. Impaired alveolar recruitment is accompanied by increased tissue stiffness in the lungs of SP-C KO 
and healthy 129Sv mice. A) Body weight (BW); B) Lung volume (ml); C) Inspiratory capacity (IC); and D) 
Static Compliance (Cst) over time. E) Tissue elastance (H) as indicator of distal lung tissue stiffness was 
obtained during forced oscillation technique and calculated according to the constant phase model at PEEP 
1cmH2O (black bars), 3cmH2O (grey bars) and 6cmH2O (white bars) for each age group, respectively, n≥ 8 
(black horizontal lines indicate statistically significant differences between the groups they connect p<0.05). 
F) tissue damping (G); and G) tissue hysteresivity (��) were assessed at 10-60 weeks of age. H) Volume 
fraction (Vv) of ventilated parenchyma (light grey) and non-ventilated parenchyma (white) within lung 
parenchyma of SP-C KO mice at different ages. Mean ± SD, n≥6; horizontal black lines with an asterisk (*) 
represents a statistical difference p<0.05 between SP-C KO vs Healthy within age groups. Statistical 
differences over age are represented in blue for the SP-C KO group and in grey for the healthy controls. 
+p<0.05 vs. 10 weeks; #p<0.05 vs. 20 weeks; §p<0.05 vs. 30 weeks; <p<0.05 vs. 40 weeks. 
220x220mm (300 x 300 DPI) 
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Figure 2. Ductal airspace over distension precedes septal thickening in the SP-C KO and healthy 129Sv lung. 
A) Representative Toluidine-blue stained micrographs of vascular perfused-fixed murine SP-C KO lungs 
(inflated with air at airway pressure = 5cmH2O), revealed thickened interalveolar septa as marker of 
microatelectasis (pink arrow) (A1-2). This was followed by alveo-ductal over distension (green arrow), which 
coincidences with alveolar size reduction in the same topographic region at an age of 20 weeks (A3-4). This 
process was found to further develop until week 30 (A5-6), predominating in the subpleural regions (A3, 
A5). At 40 weeks of age enlarged alveolar ducts localized next to prominent septal walls (arrowhead) (A7, 
A8). 10 weeks later first fibrotic lesions (yellow arrow) appeared causing tensile stress of the surrounding 
lung parenchyma (A9-10). After 60 weeks, septal wall thickening progressed, while alveolar destabilization 
in sense of collapse induration continued (A11-12). Age-dependent lung structure analysis of: B) alveolar 
airspaces density (Vv(alv/par)); C) ductal airspaces density (Vv(duct/par); D) mean linear intercept length; 
E) Mean volume weighted mean volume (ῡv(alv)); F) absolute surface of the alveolar epithelium (S(alvepi)); 
and G) Septal wall thickness (µm) were quantified within the ventilated parenchyma (V(vent-par, lung) over 
age. Mean ± SD, n≥6; horizontal black lines with an asterisk (*) represents a statistical difference p<0.05 
between SP-C KO vs Healthy within age groups. Statistical differences over age are represented in blue for 
the SP-C KO group and in grey for the healthy controls. +p<0.05 vs. 10 weeks; #p<0.05 vs. 20 weeks; 
§p<0.05 vs. 30 weeks; <p<0.05 vs. 40 weeks. 
297x209mm (300 x 300 DPI) 
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Figure 3. SP-C KO mice exhibit altered tissue composition and aberrant connective-tissue protein gene 
expression. A) Masson-Goldner trichrome staining over age, showed the abundance of dense, non-ventilated 
parenchyma areas at 10 and 50 weeks of age. At 50 weeks these lesions (arrow) were interspersed with 
collagen (green), while no collagen deposition was visible lungs from 10-week-old mice (arrowhead). B) 
Hydroxyproline level was quantified in representative tissue sections at 40, 50 and 60 weeks (*p<0.05, 
n=5) and; C-G) RT-PCR gene expression analysis of collagen 1a1, collagen 1a2, collagen 3a1, elastin and 
fibronectin in healthy and SP-C KO lungs at the ages of 10-60 weeks showed decreasing expression levels 
becoming significant for Fn, Col1a1 and Col3a1. Normalized by Gapdh; +p<0.05 vs. 10 weeks, n=5. 
297x160mm (300 x 300 DPI) 
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Figure 4. SP-C deficiency alters the innate immune system of the lung. A) Total BALF cell count assessed in 
SP-C KO and healthy 129Sv mice. B) Relative quantification of leukocyte subpopulations in BALF cells of SP-
C KO mice. C) Electron-microscopic micrograph of an IPF lung demonstrates the presence of intra-
parenchymal macrophages being loaded with electron-dense crystals (pink arrow). D) Representative 
electron-microscopic imaging of SP-C KO lungs over age demonstrates unaltered AEC2 morphology with 
physiologically shaped lamellar bodies (green arrow) (F1-6) and electron-dense intracellular inclusions with 
cleft formation in lung macrophages (pink arrow) (F7-12). Onset of crystal formation starts at 30 weeks of 
age. Detailed structural morphology of the lamellar-body-like inclusions and electron-dense clefts is provided 
on high-magnification micrographs (F13-18). Mean ± SD, n≥6; horizontal black lines with an asterisk (*) 
represents a statistical difference p<0.05 between SP-C KO vs Healthy within age groups. Statistical 
differences over age are represented in blue for the SP-C KO group and in grey for the healthy controls. 
+p<0.05 vs. 10 weeks. 
204x152mm (300 x 300 DPI) 
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Figure 5. Absence of SP-C leads to impaired cholesterol metabolism in alveolar macrophages. A) RT-PCR 
gene expression analysis of ATP binding cassette A1 (Abca1), ATP binding cassette G1 (Abcg1), cholesterol-
25-hydroxylase (Ch25h), LDL receptor (Ldlr), liver X receptor alpha (Lxra), sterol response element binding 
protein 2 (Srebp2) and chitinase like 3 or Ym1 (Chil3) in BALF cells. Normalized by Gapdh. B) Total 
Cholesterol quantification in SP-C KO and healthy 129Sv lungs per µg lung tissue at week 10-60. C) 
Fluorescent-lipid uptake by alveolar macrophages as percentage of engulfment, measure by FACS detection 
of fluorescent BAL cells from WT or SP-C KO mice. Macrophages were exposed to 0.25µg of labeled 
phospholipid per 105 cells, with/without cholesterol and/or SP-C. Black horizontal lines represents p<0.05 
between WT vs KO using a t-test, light blue horizontal lines represents p<0.05 when comparing different 
vesicle composition within the SP-C KO group using an ANOVA. D) MH-S cells, alveolar macrophage-like 
mouse cell line, were exposed to lipid vesicles laden with fluorescent cholesterol and/or SP-C and lipid 
uptake was measure in FACS as explained before. E) In another set of experiments macrophages exposed to 
vesicles with different composition during 1 h were collected for RNA isolation and RT-PCR analysis of 
expression of genes related to cholesterol metabolism and transport. F) Representative heat map of relative 
expression of the different genes using clustering by targets (right) and samples ordered by type (top). The 
green rectangle shows different targets up-regulated in the samples containing cholesterol and SP-C in 
comparison to samples containing only cholesterol or SP-C. G) Relative gene expression (ΔΔCq, normalized 
by Actb) in the different samples (n=6 per group) of the most interesting upregulated genes from the heat 
map, Pparg, SraI, Abca1, Lxrb, Abcg1, and Srebp2). Mean ± SD, n≥6; horizontal black lines with an asterisk 
(*) represents a statistical difference p<0.05 between SP-C KO vs Healthy within age groups. Statistical 
differences over age are represented in blue for the SP-C KO group and in grey for the healthy controls. 
+p<0.05 vs. 10 weeks; #p<0.05 vs. 20 weeks; §p<0.05 vs. 30 weeks; <p<0.05 vs. 40 weeks; >p<0.05 
vs. 50 weeks. 
297x209mm (300 x 300 DPI) 
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Figure 6. Structure-function relationship in the SP-C KO lung. A) Peripheral arterial oxygen saturation 
(SpO2) was measured at PEEP 3cmH2O before subsequent ventilation protocol was started in SP-C KO and 
healthy 129Sv mice; B) µCT imaging of a fixed SP-C KO lung shows distinct parenchymal lesions 
predominating in the subpleural compartments (pink arrow); C) HR-CT imaging of a 75-year-old IPF patient. 
The pathology impresses with reticular septal thickening, honeycomb-cysts, traction bronchiectasis, and 
tissue consolidation (pink arrow) in the means of UIP pattern. The pathology predominates in the subpleural 
regions and localizes in the direct neighborhood of over distended lung parenchyma. Statistically significant 
correlation of structural and mechanical parameters over the whole study period (● 10 weeks, ■ 20 weeks, 
▲ 30 weeks, ▼ 40 weeks, ◆ 50 weeks, ○ 60 weeks). D) Negative correlations between alveolar surface and 
non-ventilated parenchyma volume fraction by stereological analysis, and E) surface density and absolute 
lung volume. F) Proportional relationship of ductal volume fraction and inspiratory capacity acquired by 
FlexiVent. G) Positive correlation of mean linear intercept and absolute lung volume as independently 
determined structural parameters. H) Tissue damping and septal thickness exhibit a positive structure-
function relationship whereas I) ventilated parenchyma volume fraction and septal thickness correlate 
inversely. Mean ± SD, n≥6; horizontal black lines with an asterisk (*) represents a statistical difference 
p<0.05 between SP-C KO vs Healthy within age groups. 
297x209mm (300 x 300 DPI) 
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Supplementary Material and Methods
Animal model
SP-C deficient mice were introduced before (1) and obtained with permission from Cincinnati 
children’s hospital (Cincinnati, Ohio). 129Sv healthy mice, which served as control group, were 
acquired from Charles River GmbH (Sulzfeld, Germany). Both male and female mice were divided in 
6 groups per cohort, housed according to common European directive 2010/63 (ETS 123) conditions 
and raised for 10, 20, 30, 40, 50 or 60 weeks, respectively. All animal experiments were carried out 
according to the German “TierschutzGesetz” (TierSchG, 2013) and EU-Directive 2012/63, approved by 
the authorities of Lower Saxony (LAVES, Niedersächsisches Landesamt für Verbraucherschutz und 
Lebensmittelsicherheit) with number 16/2245. Presence of relevant murine pathogens was ruled out 
according to FELASA recommendations (2014).
Vascular perfusion fixation
In order to preserve the intra-alveolar space including alveolar surface lining, air-filled alveolar 
spaces and open capillaries lungs were fixed via the vasculature in accordance to the ATS/ERS 
consensus statement (2) and detailed in supplementary methods. Lung volume (V(lung)) was 
determined by fluid displacement according to the Archimedes principle as mean of three repetitive 
measurements and systemic uniform random sampling of lung tissue was performed as described 
before (3).
Bronchoalveolar lavage
Following analysis of alveolar dynamics, minimum 5 mice per group underwent bronchoalveolar 
lavage. After animals were euthanized by exsanguination, the trachea was cannulated, a thoracotomy 
was performed, and the pulmonary vasculature was rinsed via the right ventricle with 0.25% heparin 
in 0.9% NaCl. Subsequently, three aliquots of NaCl were actively instilled until the lungs were fully 
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inflated and the liquid was withdrawn and collected on ice. Afterwards, lungs were excised, isolated 
from non-lung tissue and frozen in cryo-tubes in liquid nitrogen for later protein or RNA isolation. 
Finally, BALF was separated from the pulmonary alveolar cells by centrifugation at 300g at 4°C for 10 
minutes and the cell free supernatant was frozen at –80°C. The pellet was treated with 1ml red blood 
cell lysis buffer (1,5mM NH4CL (Merck KGaA, Darmstadt, Germany) 100µM KHCO3 (Merck KGaA, 
Darmstadt, Germany) and 340nM EDTA (SERVA Electrophoresis GmbH, Heidelberg, Germany)) prior 
to resuspension in 100µl PBS.
Cell countings
An automated T10 cell counter (Bio-Rad Laboratories, Munich, Germany) was employed to 
quantify the number and viability of cells with trypan blue. For each group, 3-5 BALF samples were 
analyzed for cell differentials. Following immobilization by cytospinning, cytospots were stained with 
Quick-Diff. (Medion Diagnostics, 7440 SW 50 Terrace Suite 110, Miami, FL 33155) accordingly to the 
protocol. Cell counting events of macrophages, neutrophils and eosinophils were set relative to the 
total cell quantity per series of randomly generated images, employing a ZEISS Axiophot microscope 
(Zeiss, Oberkochen, Germany).
Lung mechanic and function measurements 
All animals were weighed and anesthetized via intraperitoneal injection of 80mg/kg ketamine and 
5mg/kg xylazine in 0.9% sodium chloride. Following tracheotomy, mice were connected to a small animal 
ventilator (FlexiVent, SCIREQ, Montreal, QC, Canada) and mechanical ventilation was performed as described 
previously (4) and detailed in supplementary methods. Following a short period of normal mechanical ventilation 
at a positive end expiratory pressure (PEEP) of 3 cmH2O, inspiratory capacity (IC) was measured applying a total 
lung capacity perturbation that simultaneously served as recruitment maneuver inflating the lungs up to 
30cmH2O. Perturbations based on forced oscillation technique (FOT) were repeated every 10 seconds for 100 
seconds at PEEP of 3cmH2O and input impedance was assessed. Tissue elastance (H), tissue damping (G) and 
hysteresivity (eta) were subsequently calculated by fitting the measurements to the constant phase model (5). Three 
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pressure-volume (PV) loops were recorded to determine mean quasi-static compliance (Cst) at a PEEP of 3cmH2O. 
FOT perturbations were repeated at PEEP of 1 and 6cmH2O and H was computed, analogously. Afterwards, 5-10 
animals per group underwent bronchoalveolar lavage (BAL), while minimum 6 lungs of each group were inflated 
with 30cmH2O and airway opening pressure was steadily reduced to a plateau of 5cmH2O. At a defined pressure 
of 5cmH2O, the trachea was ligated, and the animal was disconnected from the FlexiVent. Oxygen saturation in 
percentage of functional arterial hemoglobin was determined during normal mechanical ventilation at PEEP 
3cmH2O before initiating the perturbation protocol under use of a rodent oximeter (MouseOx Plus, Starr Life 
Sciences Corp., US).
Vascular perfusion fixation
In order to preserve the intra-alveolar space including alveolar surface lining, air-filled alveolar 
spaces and open capillaries lungs were fixed via the vasculature in accordance to the ATS/ERS 
consensus statement (2). After inflating the lungs at a pressure of 5cmH2O, a median laparotomy was 
performed. Caudal vena cava was depicted and abdominal aorta was incised for exsanguination before 
flushing the pulmonary vasculature via the cannulated caudal vena cava with 0.9% sodium chloride 
and 0.25% heparin at a constant pressure of 25-30cmH2O. Afterwards, the fixative (1.5% 
paraformaldehyde, 1.5% glutaraldehyde, in 0.15 M HEPES buffer) was injected. Subsequently, a 
median thoracotomy was performed. Lung lobes and mediastinal organs were excised in toto and 
further emerged in fixative for 24 hours at 4°C. Finally, the primary bronchi were ligated, and the 
inflated lung lobes were separated from non-lung tissue. Lung volume (V(lung)) was determined by 
fluid displacement according to the Archimedes principle as mean of three repetitive measurements 
and systemic uniform random sampling of lung tissue was performed as described before (3).
Design-based stereology
Design-based stereology is the gold-standard for quantitative lung structure analysis based on 
histological images enabling profound mathematical inference from 2D sections about 3D geometrical 
bodies, as which microarchitectural compartments of the distal lung have to be considered (6). 
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Stereological analysis was based on micrographs acquired at 20x magnification by a slide scanner (Axio 
Scan.Z1 (Carl Zeiss AG, Oberkochen, Germany) and subsequent automatic subsampling performed by 
the stereology Visiopharm software (Visiopharm, Horsholm, Denmark). A stereology tool 
(STEPanizer©, Bern, Switzerland) was employed for definitive stereological morphometry. A point 
grid was chosen as test system for volume estimation. Securing sufficient stereological precision, the 
number of test points was adjusted to a minimum of 200 to 300 counting events per parameter per lung 
(7). A counting event was defined as match of a structure of interest (SOI) with the test probe. At 5x 
magnification, volume fractions of parenchyma (Vv(par/lung)) and non-parenchyma (Vv(non-
par/lung)) were obtained. Parenchyma was defined as lung tissue enabling gas exchange, comprising 
septa and airspaces, and was differentiated in ventilated (Vv(ventpar/par)) and non-ventilated 
parenchyma (Vv(non-vent/par)). Pleura, conducting airways and large vessels with the surrounding 
connective tissue were defined as non-parenchyma. Volume densities of ductal airspaces 
(Vv(duct/par), alveolar airspaces (Vv(alv/par) and alveolar septa (Vv(sept/par)) were determined at 20x 
magnification within ventilated parenchyma. Herein, an additional test system consisting of 4 line-
pairs was utilized for counting intersections of test probes and alveolar surface. All analyzed 
parameters for lung structure regarding fibrosis were chosen according to recommendations from Ochs 
and Mühlfeld (7) for stereology in pulmonary fibrosis. A detailed description of investigated 
parameters and corresponding test systems is presented in table 1.
Volume densities (e.g. Vv(par/lung)) were calculated by dividing the number of points hitting the 
SOI (PSOI) by the number of points hitting the reference space, e.g. total lung.
Vv(par⁄lung) = ∑[Ppar]/∑[Ppar+Pnon-par], (1)
Multiplication of the volume fraction with total lung volume provided absolute volumes of each SOI 
(e.g. V(par,lung)):                     V(par,lung) = Vv(par⁄lung)*V(lung),   (2)
Analogous calculations were performed for parenchymal components, e.g. alveolar airspaces:
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Vv(alv⁄ven-tpar) = ∑[Palv]/∑[Pvent-par], (3)
V(alv,vent-par)=Vv(alv⁄vent-par)*V(vent-par,lung), (4)
Intersection countings (intersect) were utilized in combination with the length per point of the test 
system (l(p)) to estimate the alveolar surface density of ventilated parenchyma. The calculated absolute 
volume describes the alveolar surface contributing to pulmonary gas exchange:
Sv(alv⁄vent-par) = (2*∑[intersect])/(l(p)*∑[Pvent-par], (5) 
S(alv,lung)=Sv(alv⁄(vent-par))*V(vent-par,lung), (6)
Septal thickness was computed as follows:
Septal thickness= Vv(sept⁄par)/Sv(alv⁄par)*2, (7)
Length of test line (l(l)), number of lines per point (n(l(p)), p(alv) and n(intersect) were utilized to 
calculate the mean linear intercept length:
Mean linear intercept=2*l(l)*n(lp)*P(alv)*n(intersect), (8)
Volume weighted mean volume (ῡv) was assessed for rather detailed alveolar size and heterogeneity 
analysis (8). ῡv is independent of absolute alveolar quantity and is based on point sampled intercept 
length (PSI) (9). The PSI measures the diameter of 3D, isotropic orientated SOI, superimposing a point 
grid and a random orientated ruler on orcein stained 2D lung sections. Alveolar spaces were defined 
as SOI. As alveoli miss a clear anatomical limitation in the area of the air entrance, missing borders 
were artificially constructed as previously described (10) by closing the alveolar entrance with a straight 
line. Orcein staining accentuated the elastic fibers at the alveolar entrance rings. FOV (fields of view) 
were obtained at 20x magnification using an Axioskop light microscope DM6000B (Leica, Wetzlar, 
Germany) attached to a digital camera DP72 (Olympus, Hamburg, Germany). Subsequent random 
subsampling was performed employing a NewCast System (Visiopharm, Horsholm, Denmark) under 
Page 46 of 64 AJRCMB Articles in Press. Published on 10-January-2020 as 10.1165/rcmb.2019-0358OC 
 Copyright © 2020 by the American Thoracic Society 
use of Visiopharm software. A positive counting event was defined by the point grid hitting the 
alveolar space and PSI measurement was conducted as determination of the distance between the two 
intersections of alveolar boundaries and test ruler. The resulting PSI length of each counting event were 
utilized to calculate the ῡv of every analyzed alveolus following(11):
ῡv = π/3*PSI3 (9)
Histological sections and staining
Tissue slices were embedded into hydroxyethylmethacrylate (Technovit 8100, Kulzer Heraeus, 
Wehrheim, Germany). For further design-based stereology on light microscope level, minimum 3 tissue 
specimen per lung were cut in sections of 1.5µm thickness and stained with 0.1% toluidine blue or 0.2% 
orcein. Simultaneously, lung cubes were sampled randomly for representative electron microscope 
(EM) imaging. Cubes were embedded in Epon (Serva, Heidelberg, Germany), while 1% osmium 
tetroxide (EMS, Hatfield, PA) and 4% uranyl acetate (Serva, Heidelberg, Germany) served as contrast 
agent. Remaining tissue slices were embedded in paraffin and stained with a Masson-Goldner staining 
kit (Merck, Darmstadt, Germany) for detection of connective tissue (green). Immunostaining of human 
tissue sections is detailed in supplementary methods.
Immunohistochemistry
Fixation of human lungs was performed in 4% formaldehyde. Afterwards lung probes were 
embedded in formalin and serial sections (3µm thickness) were cut. The latter were stained with 
hematoxylin & eosin. AP-fast red kit (Zytochem systems, Berlin, Germany) was employed in 
accordance to the manufacturer’s instructions for immunohistochemical localization of pro-SP-C 
(Seven Hills). Microwaving the sections in 10mM Sodium citrate buffer, pH 6.0 was utilized for antigen 
retrieval. Hemalaun was used for counter-staining.
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Hydroxyproline assay
Hydroxyproline content was measured in accordance to the protocol established by Reddy and 
Enwemeka (12). Approximately 40mg of lung tissue were homogenized in 200µl ultrapure water and 
total protein concentration was measured by a BCA assay (Pierce® BCA Protein Assay Kit, Thermo 
Scientific, Rockford, IL, USA). Lung homogenate was dried overnight at 65°C and hydrolyzed in 6N 
HCl at 100°C for 24 hours. After neutralization with 6N NaOH, 25µl of sample were dried at 65°C. 
Next, Chloramine T reagent was applied for oxidation at room temperature. For colorimetric reaction 
equal volumes of Ehrlich’s reagent were added and samples were heated up to 65°C for 20 minutes. 
Subsequently, absorbance was measured at 570nm and hydroxyproline concentration was calculated 
according to a standard row.
Cholesterol assay
Representative frozen lung pieces were initially weighed and stored in polypropylene tubes. 
Chloroform (66,67%) and methanol (33,33%) serving as organic solvent for cholesterol drainage, was 
added and tissue homogenization was performed. After centrifugation (15.000g, 10minutes) total 
cholesterol concentration was quantified following instructions of “Total Cholesterol Assay Kit 
(Colorimetric)” (Cell Biolabs, Inc., San Diego, CA 92126). Esterified cholesterol was released for 
quantification using cholesterol esterase, being included in the kit. Total cholesterol amount was set 
relative to absolute mass of homogenized lung specimen.   
Engulfment of cholesterol-laden lipid vesicles with or without SP-C
To analyze the engulfment of lipid vesicles by alveolar macrophages, cells incubated with different 
types of fluorescently labeled vesicle were analyzed by flow cytometry using a MACSQuant 10 
analyzer (Miltenyi Biotech, Cologne, Germany). 
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The phospholipid fraction (PL) of porcine pulmonary surfactant (13) and proteins in Chl/MeOH 
were mixed in the indicated proportions and labeled with 5wt% of TopFluor cholesterol (23-
(dipyrrometheneboron difluoride)-24-norcholesterol, Avanti Polar Lipids) in Chl/MeOH 2:1 v/v. 
Samples were protected from light to avoid fluorescence bleaching. Solvents were evaporated in a fume 
hood at 40°C and samples maintained in a vacuum oven at 50°C overnight. Lipid films were hydrated 
to 0.5 mg/ml with 50 mM Tris pH 7.0 150 mM NaCl at 60oC for 1h at 1400 rpm in a Thermo–Shaker TS-
100C (BioSan, Riga, Latvia).
For the cytometry experiments, 105 cells/well in 90µl PBS were administrated 10µl lipid 
suspensions and incubated at room temperature for the indicated times and lipid concentrations (see 
Results). Cells were re-suspended by pipetting before and after lipid addition and just prior flow 
cytometry measurements. At least 10.000 events were recorded per sample. Vesicle engulfment was 
detected in the FITC channel and quantified by stablishing a threshold according to the fluorescence 
detected from non-treated cells. Data were analyzed with MacsQuant software (Miltenyi Biotec; 
Cologne, Germany) and GraphPad Prism 5 (La Jolla, CA, USA).
Real time - PCR
RNA was isolated from homogenized, post-lavage lungs following ISOLATE II RNA Mini Kit 
instructions (ISOLATE RNA Mini Kit, Bioline GmbH, Luckenwalde, Germany). RNA quantity was 
determined by spectrophotometry at 260nm, employing a nanodrop 2000 (NANODROP 2000, 
Spectrophotometer, Thermo Scientific). 1µg of RNA per sample was used for reverse transcription 
following instructions of the iScript™ cDNA Synthesis Kit (Bio-Rad Lab). cDNA synthesis was 
performed in a Thermal Cycler (CFX96TM, Bio-Rad Laboratories, Munich, Germany). Subsequent RT-
PCR was performed with iTaq Universal SYBR Green Supermix (Bio-Rad Laboratories, Munich, 
Germany), mixing 100ng of primer with 50ng cDNA. An initial 3 min denaturation phase at 95°C served 
as activation step for the antibody repressed iTaq polymerase. In the annealing and extension phase, 
temperature was decreased to 59°C for 30s for 40 cycles under employment of a CFX96 Thermal Cycler 
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(CFX96TM, Bio-Rad Laboratories, Munich, Germany). Primers were designed with the application 
PrimerBlast (National Center for Biotechnology Information, U.S. National Library of Medicine, USA) 
and synthetized by Eurofins Genomics (Ebersberg, Germany). Primer sequences are shown in detail in 
table 2. Quantification of the amplification data was assessed in the early exponential stage of the 
replication phase and normalized rate of gene expression (ΔΔCq) was chosen for RT-PCR data 
representation, relating amplification data to reference gene amplification and control sample (week 
10). Delta delta Ct (Ct) method is a direct comparison of Ct values between the target gene and the 
reference gene (b-ACTIN, GAPDH). Relative quantification involves the choice of a calibrator sample 
(week 10). Firstly, the Ct between the target gene and the reference gene is calculated for each sample 
(for the unknown samples and also for the calibrator sample). Ct = Cttarget – Ctreference gene. Then the 
difference between the Ct of the unknown and the Ct of the calibrator is calculated, giving the Ct 
value: Ct = (Cttarget – Ctreference)calibrator – (Cttarget – Ctreference)sample. Data is presented as Mean + SD; Group 
size n=3-5.
Statistical analysis
Graphs and statistical analysis were conducted with GraphPad Prism 6.0 (GraphPad Software, San 
Diego, CA, USA). Data is presented as scattered dot plot (with mean+SD), bar chart (mean + SD) or 
boxplot. Statistical differences between controls and KO are presented in the text, differences within 
control or SP-C KO groups are presented in the graphs and effect differences between group (genotype) 
versus time are presented in supplementary table 3. Multiple group comparisons were analyzed by a 
one-way ANOVA test and corrected with a Bonferroni post-hoc analysis comprising a 95% confidence 
interval. Mixed-effects model was used to compare genotype (group) versus time. Correlation analyses 
were performed applying the Spearman test and linear regression using the software SPSS (IBM, 
Ehningen, Germany). Overall, p-values <0.05 were considered statistically significant.
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Results
Age related changes in lung mechanics in healthy 129Sv mice
Tissue elastance measurements pointed towards a pressure dependent recruitment of airspaces 
resulting in lower tissue elastance at higher PEEP (Suppl. Figure 1A). In fact, an increase in PEEP was 
continuously sufficient to significantly lower tissue elastance at every studied age in the healthy 129Sv 
cohort. When comparing age groups, tissue elastance exhibited a steady decline with increasing age at 
a PEEP of 1 and 3 cmH2O whereas the decrease with age was rather neglectable at a PEEP of 6cmH2O. 
Age related changes in lung morphology in healthy 129Sv mice
Histological sections (Suppl. Figure 2A) showed minor changes of lung general morphology 
during the 60 weeks’ time course in healthy 129Sv mice. 
Age-dependent analysis of tissue composition and connective-tissue protein gene expression in 
healthy 129Sv mice.
Masson-Goldner stained lung sections showed neither increased of interstitial collagen 
deposition nor fibrotic lesions (Suppl. Figure 3A). Instead, homogeneously ventilated lung 
parenchyma was depicted. Likewise, hydroxyproline quantification demonstrated no age-
dependent alterations between week 40-60 (Suppl. Figure 3B). In contrast, gene expression analysis 
of connective-tissue related genes revealed a significant age-related expression pattern: expression 
of the investigated genes Col1a1, Col2a1, Col3a1, Eln and Fn initially decreased by age (Suppl. 
Figure 3C-3G). Minimum expression rates were seen at 40 weeks of age. While elastin expression 
remained constant at a basal expression level, transcription rate of matrix fibers contributing to 
lung stiffness like collagen3a1 and fibronectin showed a significant increase at week 60 compared 
to week 40, what may contribute to the age-related parenchymal restructuration, which was seen 
before. 
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Age-dependent analysis of BALF cells in healthy 129/Sv mice.
Healthy 129Sv mice showed unaltered BALF cell quantity over the whole study timeframe 
(Figure 4A). Therein, only neglectable amounts of neutrophils were detected (Suppl. Figure 4A).
Age-dependent analysis of expression of genes related to the cholesterol metabolism in healthy 
129/Sv mice.
Gene expression analysis of cholesterol metabolism related genes generally showed steady 
expression level over age. However, a significant age dependent decrease in gene expression between 
week 30 and 40 was noted for Abcg1, Ch25h and Srebp2 (Supp. Figure 5A). Correspondingly, total lung 
cholesterol amount was significantly increased from week 30 to 40 (Figure 5B).
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Supplementary Figure Legends
Suppl. Figure 1 Age related changes in lung mechanics in healthy 129Sv mice. E) Tissue elastance at 
PEEP 1cmH2O (black), 3cmH2O (grey) and 6cmH2O (white); Mean ± SD, n≥5. 
Suppl. Figure 2. Age related changes in lung morphology in healthy 129Sv mice. A) Representative 
Toluidine-blue stained micrographs of vascular perfused-fixed healthy 129Sv lungs. 
Suppl. Figure 3. Age-dependent analysis of tissue composition and connective-tissue protein gene 
expression in healthy 129Sv mice. A) Masson-Goldner trichrome staining of lungs from healthy 129Sv 
mice at (left to right top panel) 10, 20, 30, and 40, 50 and 60 weeks of age (left to right bottom panel); B) 
hydroxyproline level was quantified in representative tissue sections at 40, 50 and 60 weeks (n=5).  RT-
PCR gene expression analysis of: C) collagen 1a1; D) collagen 2a1; E) collagen 3a1; F) elastin; and G) 
fibronectin in healthy 129Sv lungs at ages of 10-60 weeks in lung tissue. Gene expression of all 
investigated genes significantly decreased from week 10 to week 30-40, where after gene expression 
tended to increase. Minimum gene expression was continuously found at week 40. Normalized by 
Gapdh; +p<0.05 vs. 10 weeks; #p<0.05 vs. 20 weeks, §p<0.05 vs. 30 weeks. <p<0.05 vs. 40 weeks. 
Suppl. Figure 4. Age-dependent analysis of BALF cells in healthy 129/Sv mice. B) relative 
quantification of leukocyte subpopulations in BALF cells of healthy 129Sv mice.
Suppl. Figure 5. Age-dependent analysis of expression of genes related to the cholesterol 
metabolism in healthy 129/Sv mice. A) RT-PCR gene expression analysis of ATP binding cassette A1 
(Abca1), ATP binding cassette G1 (Abcg1), cholesterol-25-hydroxylase (Ch25h), LDL receptor (Ldlr), liver 
X receptor alpha (Lxra), sterol response element binding protein 2 (Srebp2) and chitinase like 3 (Ym1) in 
BALF cells. Expression of Abcg1, Ch25h and Srebp2 turned to significantly decrease from week 30 to 
week 40. Normalized by Gapdh. +p<0.05 vs. 10 weeks; #p<0.05 vs. 20 weeks, §p<0.05 vs. 30 weeks. 
<p<0.05 vs. 40 weeks.
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Supplementary Tables
Suppl. Table 1. Determined stereological parameters.
Parameter Determination Magnification 
Lung volume V [ml] 
V (par,lung) [ml]
V (vent-par,lung) [ml]





V (duct, lung) [ml]
V (sept, lung) [ml]
S (alvepi, vent-par) [cm2]
Septal thickness [µm]














V (sept, lung) * 2/S (alvepi, vent-par)
Intersection counting 
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Suppl. Table 2. List of primers used for RT-PCR.
Gene Protein Forward primer Reverse primer Accession 
number




Eln Elastin TCACCACCCCACCTCTTTGT CCAAAGAGCACACCAACAATCAA NM_007925.4
Col1a1 Collagen I GAG GTG ATG CTG GTC CCA A AGC TTC ACC CTT GTC ACC A NM_007742.3
Col1a2 Collagen I GAA CTG GAG AAA CAG GTG 
CA
GAG CAC CAA GAA GAC CCT GA NM_007743.2
Col3a1 Collagen 
III
GTG ACA AAG GTG AAA CTG 
GTG A
TAC CAA TTG CAC CCT GGT GA NM_009930.2
Abca1 ABCA1 GCGACCATGAAAGTGACACG CAGCACATAGGTCAGCTCGT NM_013454.3






Chil3 YM1 GTG GAG CCT AAG GAA GAG 
GC




Nr1h3 LXRα CAGGTTGGGTGTTTTCTGGC GAAGAACCCTGCACAAAGTGG NM_001177730.1
Srebp2 SREBP TGATGATCACCCCGACGTTC GTCACGAGGCTTTGCACTTG NM_033218.1
Lpla2 LPLA2 ACCCCAGCAAGAGGAATGTG CCGTTTTCATTTGGGGCTCG NM_133792.2
Lipa LAL CCACCAAGTAGGTGTAGGCAC TGCATCTTCCGGGAGTGGT NM_021460.3
Dhcr24 DHCR24 GATGAATGGTCAACGCGAGC TTTGGGTGACACAGGTTGCT NM_053272.2
Cd36 CD36 ATGAATGGTTGAGACCCCGTG GATTGGCTTCAGGGAGACTGT NM_001159558.1
Cyp27a1 CYP27A1 GGTCGGAGGATTGCAGAACT GGTCGGAGGATTGCAGAACT NM_024264.5
Npc1 NPC1 AAAGGCAACGTGTTCTTCACAG GTTAAAACCCATGAGCGTTGTCT NM_008720.2
Npc2 NPC2 CATTGTCCCCCGAGATAGCC CCATCCTGTCTGGTGGAACC NM_023409.4




Msr1 SRA1 CCTTTCACCTCTGGACAAGTCA ATGTCAATGGAGGCCCCAAC NM_031195.2
Nr1h2 LXRβ CTCGGTCCAGGAGATTGTGG CTGTCTCGTGGTTGTAGCGT NM_001285518.1
Page 57 of 64  AJRCMB Articles in Press. Published on 10-January-2020 as 10.1165/rcmb.2019-0358OC 
 Copyright © 2020 by the American Thoracic Society 
Suppl. Table 3. Mixed-effects model to differentiate the potential contibution of the genotype (group) 
versus time in the changes of different parameters measured.
p-value
Parameter Group (Control vs KO) Time (weeks)
BW 0.0042 <0.0001
Lung volume 0.0005 <0.0001
IC <0.0001 <0.0001
Cst <0.0001 <0.0001
H PEEP 1 cmH2O <0.0001 <0.0001
H PEEP 3 cmH2O <0.0001 <0.0001









Septal thickness 0.0338 0.0005
Total BAL cells <0.0001 ns
Total cholesterol ns <0.0001
SpO2 <0.0001 ns
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Suppl. Table 4. Age related changes in lung morphometry in healthy 129Sv mice. Absolute 
stereological lung volumes are given with mean and standard deviation (SD) for every age group. 
V(par,lung) = absolute lung parenchyma volume; V(non-par,lung) = absolute non-parenchyma volume; 
V(vent-par,lung) = absolute ventilated parenchyma volume; V(non-vent-par,lung) = absolute non-
ventilated parenchyma volume; V(alv,lung) = absolute alveolar space volume; V(duct,lung) = Absolute 
ductal airspace volume; V(sept,lung) = absolute alveolar septum volume.
 10 weeks 20 weeks 30 weeks 40 weeks 50 weeks 60 weeks
Parameter[ml]  Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
V(par,lung) 0.47 0.07 0.54 0.05 0.66 0.08 0.46 0.05 0.56 0.03 0.55 0.09
V(non-par,lung) 0.06 0.02 0.08 0.03 0.10 0.02 0.08 0.02 0.09 0.03 0.07 0.01
V(vent-par,lung) 0.46 0.07 0.53 0.05 0.66 0.09 0.46 0.05 0.56 0.03 0.54 0.09
V(non-vent-
par,lung) 0.01 0.01 0.01 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
V(alv,lung) 0.24 0.04 0.27 0.03 0.35 0.04 0.22 0.03 0.28 0.02 0.25 0.05
V(duct,lung) 0.16 0.03 0.20 0.02 0.25 0.05 0.20 0.03 0.23 0.05 0.24 0.05
V(sept,lung) 0.05 0.01 0.06 0.01 0.06 0.02 0.04 0.01 0.05 0.01 0.06 0.01
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Suppl. Figure 1 Age related changes in lung mechanics in healthy 129Sv mice. E) Tissue elastance at PEEP 
1cmH2O (black), 3cmH2O (grey) and 6cmH2O (white); Mean ± SD, n≥5. 
209x297mm (300 x 300 DPI) 
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Suppl. Figure 2. Age related changes in lung morphology in healthy 129Sv mice. A) Representative 
Toluidine-blue stained micrographs of vascular perfused-fixed healthy 129Sv lungs. 
139x209mm (300 x 300 DPI) 
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Suppl. Figure 3. Age-dependent analysis of tissue composition and connective-tissue protein gene 
expression in healthy 129Sv mice. A) Masson-Goldner trichrome staining of lungs from healthy 129Sv mice 
at (left to right top panel) 10, 20, 30, and 40, 50 and 60 weeks of age (left to right bottom panel); B) 
hydroxyproline level was quantified in representative tissue sections at 40, 50 and 60 weeks (n=5).  RT-PCR 
gene expression analysis of: C) collagen 1a1; D) collagen 2a1; E) collagen 3a1; F) elastin; and G) 
fibronectin in healthy 129Sv lungs at ages of 10-60 weeks in lung tissue. Gene expression of all investigated 
genes significantly decreased from week 10 to week 30-40, where after gene expression tended to increase. 
Minimum gene expression was continuously found at week 40. Normalized by Gapdh; +p<0.05 vs. 10 
weeks; #p<0.05 vs. 20 weeks, §p<0.05 vs. 30 weeks. <p<0.05 vs. 40 weeks. 
297x160mm (300 x 300 DPI) 
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Suppl. Figure 4. Age-dependent analysis of BALF cells in healthy 129/Sv mice. B) relative quantification of 
leukocyte subpopulations in BALF cells of healthy 129Sv mice. 
90x52mm (300 x 300 DPI) 
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Suppl. Figure 5. Age-dependent analysis of expression of genes related to the cholesterol metabolism in 
healthy 129/Sv mice. A) RT-PCR gene expression analysis of ATP binding cassette A1 (Abca1), ATP binding 
cassette G1 (Abcg1), cholesterol-25-hydroxylase (Ch25h), LDL receptor (Ldlr), liver X receptor alpha (Lxra), 
sterol response element binding protein 2 (Srebp2) and chitinase like 3 (Ym1) in BALF cells. Expression of 
Abcg1, Ch25h and Srebp2 turned to significantly decrease from week 30 to week 40. Normalized by Gapdh. 
+p<0.05 vs. 10 weeks; #p<0.05 vs. 20 weeks, §p<0.05 vs. 30 weeks. <p<0.05 vs. 40 weeks. 
209x99mm (300 x 300 DPI) 
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